Literature DB >> 19892665

Autofluorescence-guided surveillance for oral cancer.

Vijayvel Jayaprakash1, Maureen Sullivan, Mihai Merzianu, Nestor R Rigual, Thom R Loree, Saurin R Popat, Kirsten B Moysich, Soumya Ramananda, Timothy Johnson, James R Marshall, Alan D Hutson, Thomas S Mang, Brian C Wilson, Steven R Gill, Jennifer Frustino, Arjen Bogaards, Mary E Reid.   

Abstract

Early detection of oral premalignant lesions (OPL) and oral cancers (OC) is critical for improved survival. We evaluated if the addition of autofluorescence visualization (AFV) to conventional white-light examination (WLE) improved the ability to detect OPLs/OCs. Sixty high-risk patients, with suspicious oral lesions or recently diagnosed untreated OPLs/OCs, underwent sequential surveillance with WLE and AFV. Biopsies were obtained from all suspicious areas identified on both examinations (n = 189) and one normal-looking control area per person (n = 60). Sensitivity, specificity, and predictive values were calculated for WLE, AFV, and WLE + AFV. Estimates were calculated separately for lesions classified by histopathologic grades as low-grade lesions, high-grade lesions (HGL), and OCs. Sequential surveillance with WLE + AFV provided a greater sensitivity than WLE in detecting low-grade lesions (75% versus 44%), HGLs (100% versus 71%), and OCs (100% versus 80%). The specificity in detecting OPLs/OCs decreased from 70% with WLE to 38% with WLE + AFV. Thirteen of the 76 additional biopsies (17%) obtained based on AFV findings were HGLs/OCs. Five patients (8%) were diagnosed with a HGL/OC only because of the addition of AFV to WLE. In seven patients, additional HGL/OC foci or wider OC margins were detected on AFV. Additionally, AFV aided in the detection of metachronous HGL/OC in 6 of 26 patients (23%) with a history of previously treated head and neck cancer. Overall, the addition of AFV to WLE improved the ability to detect HGLs/OCs. In spite of the lower specificity, AFV + WLE can be a highly sensitive first-line surveillance tool for detecting OPLs/OCs in high-risk patients.

Entities:  

Mesh:

Year:  2009        PMID: 19892665      PMCID: PMC3653312          DOI: 10.1158/1940-6207.CAPR-09-0062

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  48 in total

1.  Fluorescence visualization in oral neoplasia: shedding light on an old problem.

Authors:  William H Westra; David Sidransky
Journal:  Clin Cancer Res       Date:  2006-11-15       Impact factor: 12.531

2.  Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation.

Authors:  Omar Kujan; Richard J Oliver; Ammar Khattab; Stephen A Roberts; Nalin Thakker; Philip Sloan
Journal:  Oral Oncol       Date:  2006-05-30       Impact factor: 5.337

3.  Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device.

Authors:  Catherine F Poh; Samson P Ng; P Michele Williams; Lewei Zhang; Denise M Laronde; Pierre Lane; Calum Macaulay; Miriam P Rosin
Journal:  Head Neck       Date:  2007-01       Impact factor: 3.147

4.  Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions.

Authors:  S Ram; C H Siar
Journal:  Int J Oral Maxillofac Surg       Date:  2005-01-26       Impact factor: 2.789

5.  The efficacy of oral lumenoscopy (ViziLite) in visualizing oral mucosal lesions.

Authors:  Joel B Epstein; Meir Gorsky; Stewart Lonky; Sol Silverman; Joshua D Epstein; Mark Bride
Journal:  Spec Care Dentist       Date:  2006 Jul-Aug

Review 6.  Visualization and other emerging technologies as change makers for oral cancer prevention.

Authors:  Miriam P Rosin; Catherine F Poh; Martial Guillard; P Michele Williams; Lewei Zhang; Calum MacaUlay
Journal:  Ann N Y Acad Sci       Date:  2007-03-01       Impact factor: 5.691

7.  Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients.

Authors:  Catherine F Poh; Lewei Zhang; Don W Anderson; J Scott Durham; P Michele Williams; Robert W Priddy; Ken W Berean; Samson Ng; Olivia L Tseng; Calum MacAulay; Miriam P Rosin
Journal:  Clin Cancer Res       Date:  2006-11-15       Impact factor: 12.531

8.  Cancer statistics, 2007.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2007 Jan-Feb       Impact factor: 508.702

Review 9.  Pathology of malignant and premalignant oral epithelial lesions.

Authors:  Robert O Greer
Journal:  Otolaryngol Clin North Am       Date:  2006-04       Impact factor: 3.346

10.  Workshop on imaging science development for cancer prevention and preemption.

Authors:  Gary J Kelloff; Daniel C Sullivan; Houston Baker; Lawrence P Clarke; Robert Nordstrom; James L Tatum; Gary S Dorfman; Paula Jacobs; Christine D Berg; Martin G Pomper; Michael J Birrer; Margaret Tempero; Howard R Higley; Brenda Gumbs Petty; Caroline C Sigman; Carlo Maley; Prateek Sharma; Adam Wax; Gregory G Ginsberg; Andrew J Dannenberg; Ernest T Hawk; Edward M Messing; H Barton Grossman; Mukesh Harisinghani; Irving J Bigio; Donna Griebel; Donald E Henson; Carol J Fabian; Katherine Ferrara; Sergio Fantini; Mitchell D Schnall; Jo Anne Zujewski; Wendy Hayes; Eric A Klein; Angelo DeMarzo; Iclal Ocak; Jeffrey A Ketterling; Clare Tempany; Faina Shtern; Howard L Parnes; Jorge Gomez; Sudhir Srivastava; Eva Szabo; Stephen Lam; Eric J Seibel; Pierre Massion; Geoffrey McLennan; Kevin Cleary; Robert Suh; Randall W Burt; Ruth M Pfeiffer; John M Hoffman; Hemant K Roy; Thomas Wang; Paul J Limburg; Wafik S El-Deiry; Vali Papadimitrakopoulou; Walter N Hittelman; Calum MacAulay; Robert W Veltri; Diane Solomon; Jose Jeronimo; Rebecca Richards-Kortum; Karen A Johnson; Jaye L Viner; Steven P Stratton; Milind Rajadhyaksha; Atam Dhawan
Journal:  Cancer Biomark       Date:  2007       Impact factor: 4.388

View more
  14 in total

1.  Hyperspectral fluorescence microscopy detects autofluorescent factors that can be exploited as a diagnostic method for Candida species differentiation.

Authors:  Matthew S Graus; Aaron K Neumann; Jerilyn A Timlin
Journal:  J Biomed Opt       Date:  2017-01-01       Impact factor: 3.170

2.  Automatic classification of dual-modalilty, smartphone-based oral dysplasia and malignancy images using deep learning.

Authors:  Bofan Song; Sumsum Sunny; Ross D Uthoff; Sanjana Patrick; Amritha Suresh; Trupti Kolur; G Keerthi; Afarin Anbarani; Petra Wilder-Smith; Moni Abraham Kuriakose; Praveen Birur; Jeffrey J Rodriguez; Rongguang Liang
Journal:  Biomed Opt Express       Date:  2018-10-10       Impact factor: 3.732

3.  Topical MMP beacon enabled fluorescence-guided resection of oral carcinoma.

Authors:  Laura Burgess; Juan Chen; Nikolaus E Wolter; Brian Wilson; Gang Zheng
Journal:  Biomed Opt Express       Date:  2016-02-29       Impact factor: 3.732

4.  Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer.

Authors:  Katelyn D Bothwell; Tatiana Shaurova; Mihai Merzianu; Amritha Suresh; Moni A Kuriakose; Candace S Johnson; Pamela A Hershberger; Mukund Seshadri
Journal:  Cancer Prev Res (Phila)       Date:  2015-06-22

Review 5.  Role of near-infrared fluorescence imaging in head and neck cancer surgery: from animal models to humans.

Authors:  Ihab Atallah; Clément Milet; Jean-Luc Coll; Emile Reyt; Christian Adrien Righini; Amandine Hurbin
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-13       Impact factor: 2.503

Review 6.  Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.

Authors:  Richard Macey; Tanya Walsh; Paul Brocklehurst; Alexander R Kerr; Joseph L Y Liu; Mark W Lingen; Graham R Ogden; Saman Warnakulasuriya; Crispian Scully
Journal:  Cochrane Database Syst Rev       Date:  2015-05-29

7.  Effectiveness of autofluorescence to identify suspicious oral lesions--a prospective, blinded clinical trial.

Authors:  Felix Peter Koch; Peer W Kaemmerer; Stefan Biesterfeld; Martin Kunkel; Wilfried Wagner
Journal:  Clin Oral Investig       Date:  2010-08-17       Impact factor: 3.573

Review 8.  Real-time fluorescence image-guided oncologic surgery.

Authors:  Suman B Mondal; Shengkui Gao; Nan Zhu; Rongguang Liang; Viktor Gruev; Samuel Achilefu
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

9.  The use of Velscope to assess cellular changes occuring in oral premalignancy.

Authors:  Sonal Shah; Pushkar Waknis; Aditi Saha; Sneha Setiya; Tusha Ratra; Vibha Vaswani
Journal:  J Oral Biol Craniofac Res       Date:  2020-03-14

10.  Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.

Authors:  Tanya Walsh; Richard Macey; Alexander R Kerr; Mark W Lingen; Graham R Ogden; Saman Warnakulasuriya
Journal:  Cochrane Database Syst Rev       Date:  2021-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.